If Yap activation inhibits ccRCC cancer cell growth in 2D cultures by impeding p65/ZHX2 cooperativity, one would predict that increasing the level of either ZHX2 or p65 may rescue ccRCC cancer cell growth inhibited by XMU-MP-1. Here, ZHX2 is linked to nonpapillary renal cell carcinoma.